Anti-Snoring Treatment Market Report 2026

The anti-snoring treatment market size has grown strongly in recent years. It will grow from $2.54 billion in 2025 to $2.76 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of sleep-related breathing disorders, rising consumer awareness of sleep health, wider availability of over-the-counter snoring devices, expansion of sleep clinics, growing use of oral appliance therapy.

The anti-snoring treatment market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing integration of digital sleep monitoring technologies, rising adoption of personalized sleep therapy solutions, expansion of online distribution channels, growing focus on preventive sleep health management, increasing demand for minimally invasive snoring treatments. Major trends in the forecast period include increasing adoption of smart wearable anti-snoring devices, rising demand for non-invasive treatment options, growing preference for home-based snoring solutions, expansion of personalized oral appliance therapies, enhanced focus on sleep quality improvement.

The increasing prevalence of sleep disorders is anticipated to drive the growth of the anti-snoring treatment market in the coming years. Sleep disorders are conditions that disrupt normal sleep patterns, affecting the quality, duration, or timing of sleep and resulting in impaired daily functioning. The rise in sleep disorders can be linked to higher stress levels, which increase the body’s stress hormones and interfere with the ability to fall and remain asleep. Anti-snoring treatments work to enhance sleep quality by minimizing breathing interruptions, which can help manage sleep disorders such as sleep apnea and prevent associated health complications. For example, in November 2023, according to the National Health Service, a UK-based government health statistics body, the percentage of young people aged 17 to 23 experiencing sleep problems three or more times in the past week increased slightly to 64.9%, compared to 64% in 2022. Consequently, the rising prevalence of sleep disorders is fueling the growth of the anti-snoring treatment market.

The rising healthcare expenditure is anticipated to drive the growth of the anti-snoring treatment market in the coming years. Healthcare expenditure encompasses the total spending on health-related goods and services, including hospital care, physician services, prescription medications, and medical equipment. This spending is increasing mainly due to an aging population, which leads to higher demand for medical services as older adults require more frequent and intensive healthcare interventions. Greater healthcare spending directly facilitates improved access to diagnostic services and treatment options for conditions such as snoring and sleep apnea. For example, in June 2025, according to the Centers for Medicare & Medicaid Services, a US-based government agency, national health expenditures (NHE) in 2023 increased by 7.5%, reaching $4.9 trillion, which averages $14,570 per person and accounts for 17.6% of the Gross Domestic Product (GDP). Spending on Medicare rose by 8.1% to $1.02 trillion, representing 21% of total NHE. Consequently, the increase in healthcare expenditure is supporting the growth of the anti-snoring treatment market.

Major companies operating in the anti-snoring treatment market are concentrating on developing advanced solutions, such as AIoT-enabled smart pillows and mattresses, to improve sleep quality, reduce snoring, and mitigate related health risks. AIoT sleep technologies combine artificial intelligence with the Internet of Things to track physiological parameters, analyze sleep patterns, and deliver real-time adjustments for optimal rest. For example, in December 2023, The DeRUCCI Group, a China-based public company and sleep technology brand, introduced a smart anti-snore pillow featuring AI-driven monitoring and intervention. The pillow automatically adjusts head position for maximum effectiveness, provides app-based sleep tracking, and connects with other smart home devices to create a personalized sleep environment. It includes intelligent height adjustment to support neck curves and relieve fatigue, employs AI algorithms to monitor body shape, sleeping position, heart rate, and body temperature, and delivers detailed sleep reports along with health alerts.

Major companies operating in the anti-snoring treatment market are GlaxoSmithKline plc, Medtronic plc, Koninklijke Philips N.V, Mitsui Chemicals Inc, ResMed, Fisher & Paykel Healthcare​, PANTHERA DENTAL, SomnoMed, ProSomnus Sleep Technologies, Airing Inc., Apnea Sciences Corporation, Hupnos, MEDiTAS Ltd, MPowrx Health & Wellness, Sleeping Well LLC, Smart Nora Inc., The Pure Sleep Company, The Snore Reliever Company LLC, Theravent Inc, Oscimed SA, Zzoma.

North America was the largest region in the anti-snoring treatment market in 2025. The regions covered in the anti-snoring treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anti-snoring treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the anti-snoring treatment market by increasing costs of imported medical-grade plastics, electronic components, sensors, and manufacturing equipment used in CPAP devices, smart wearables, and oral appliances. North America and Europe are most affected due to reliance on imported device components, while Asia-Pacific faces pricing pressure in export-oriented manufacturing. These tariffs are increasing product prices and slowing device upgrades for consumers. At the same time, they are encouraging domestic device manufacturing, local assembly of components, and innovation in cost-efficient and digitally enabled anti-snoring solutions.

The anti-snoring treatment market research report is one of a series of new reports that provides anti-snoring treatment market statistics, including anti-snoring treatment industry global market size, regional shares, competitors with a anti-snoring treatment market share, detailed anti-snoring treatment market segments, market trends and opportunities, and any further data you may need to thrive in the anti-snoring treatment industry. This anti-snoring treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anti-snoring treatment involves different approaches designed to lessen or stop snoring, which occurs due to the vibration of tissues in the upper airway during sleep. These methods address factors such as airway blockage, muscle relaxation, or nasal congestion to enhance sleep quality and prevent associated health issues.

The primary categories of devices used in anti-snoring treatment include mandibular advancement devices, tongue stabilizing devices, nasal devices, continuous positive airway pressure devices, chin straps, and others. Mandibular advancement devices are designed to reduce snoring by gently moving the lower jaw forward, which helps maintain an open airway during sleep. These devices are available through hospital pharmacies, retail pharmacies, online platforms, and other channels for various applications, including somnoplasty, maxillomandibular and genioglossus advancement surgeries, radiofrequency ablation surgery, and more, serving a range of end users such as hospitals and clinics, ambulatory surgical centers, day care centers, and others.

The anti-snoring treatment market includes revenues earned by entities by providing services such as sleep disorder diagnosis, device fitting and customization, behavioral therapy, surgical treatments, and home care and monitoring services. The anti-snoring treatment market also includes sales of nasal dilators, positional therapy devices, tongue-retaining devices, and mandibular advancement devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.